$PMVP 4 SEC Filings

Filed On	Filing
05 Oct 2026	Form 4: Eckler Matthew Joseph, Director Granted 84,000 Stock Option (right to buy)
05 Jun 2026	Form 4: Stelzer Laurie, Director Granted 42,000 Stock Option (right to buy)
05 Jun 2026	Form 4: Levine Arnold J, Director Granted 42,000 Stock Option (right to buy)
05 Jun 2026	Form 4: Gallagher Carol Giltner, Director Granted 42,000 Stock Option (right to buy) · Gave 42,000 Stock Option (right to buy) as a gift · Acquired 42,000 Stock Option (right to buy) (Gift)
05 Jun 2026	Form 4: Flowers Kirsten, Director Granted 42,000 Stock Option (right to buy)
05 Jun 2026	Form 4: Baum Charles M, Director Granted 42,000 Stock Option (right to buy)
09 Mar 2026	Form 4: Carulli Michael, Chief Financial Officer Granted 240,000 Employee Stock Option (right to buy)
09 Mar 2026	Form 4: Ticktin Robert, General Counsel & COO Granted 319,270 Employee Stock Option (right to buy)
09 Mar 2026	Form 4: Jalota Deepika, Chief Development Officer Granted 303,310 Employee Stock Option (right to buy)
09 Mar 2026	Form 4: Mack David Henry, Director Granted 744,960 Employee Stock Option (right to buy)
29 Oct 2025	Form 4: Mack David Henry, Director Received 220,643 shares by exercise or conversion ($302K)
27 Oct 2025	Form 4: Orbimed Advisors Llc, 10% owner and 1 other Sold 1,000,000 shares ($1.52M)
12 Sep 2025	Form 4: Orbimed Advisors Llc, 10% owner and 1 other Sold 500,000 shares ($900K)
03 Jul 2025	Form 4: Ticktin Robert, General Counsel & COO Sold 23,151 shares ($24.7K)
03 Jul 2025	Form 4: Jalota Deepika, Chief Development Officer Sold 33,065 shares ($35.2K)
03 Jul 2025	Form 4: Carulli Michael, Chief Financial Officer Sold 28,249 shares ($30.1K)
03 Jul 2025	Form 4: Mack David Henry, Director Sold 58,411 shares ($62.2K)
09 Jun 2025	Form 4: Stelzer Laurie, Director Granted 33,500 Stock Option (right to buy)
09 Jun 2025	Form 4: Levine Arnold J, Director Granted 33,500 Stock Option (right to buy)
09 Jun 2025	Form 4: Heyman Richard A., Director Granted 33,500 Stock Option (right to buy)

Comments